NCT00294762 · Interventional trial
Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
Overall registry status Completed
Phase 2
Conditions Carcinoma, Non-Small-Cell Lung
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- Hematology-Oncology Associates, SJ, PA - Virtua Health · Mount Holly, NJ · Burlington County
First posted
Registry updated
Added to the directory